Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites

被引:35
作者
Han, JQ
Wroblewski, G
Xu, Z
Silverman, RH
Barton, DJ
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA
[3] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[4] Ridgeway Biosyst Inc, Cleveland, OH 44106 USA
关键词
D O I
10.1089/jir.2004.24.664
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ribonuclease L ( RNase L) cleaves RNA predominantly at single-stranded UA and UU dinucleotides. Intriguingly, hepatitis C virus (HCV) RNAs have a paucity of UA and UU dinucleotides, and relatively interferon (IFN)-resistant strains have fewer UA and UU dinucleotides than do more IFN-sensitive strains. In this study, we found that contextual features of UA and UU dinucleotides dramatically affected the efficiency of RNase L cleavage in HCV RNA. HCV genotype 1a RNA was cleaved by RNase L into fragments 200-1000 bases in length, consistent with 10-50 RNase L cleavage sites within the 9650-base long viral RNA. Using primer extension, we found that HCV RNA structures with multiple single-stranded UA and UU dinucleotides were cleaved most efficiently by RNase L. UA and UU dinucleotides with 3' proximal C or G residues were cleaved infrequently, whereas UA and UU dinucleotides within dsRNA structures were not cleaved. 5'-GUAC-3' and 5'-CUUC-3' were particularly unfavorable contexts for cleavage by RNase L. More than 60% of the UA and UU dinucleotides in HCV 1a RNA were not cleaved by RNase L because of these contextual features. The 10-30 most efficiently cleaved sites were responsible for similar to50%-85% of all RNase L cleavage events. Our data indicate that a relatively small number of the UA and UU dinucleotides in HCV RNA mediate the overall sensitivity of HCV RNA to cleavage by RNase L.
引用
收藏
页码:664 / 676
页数:13
相关论文
共 40 条
[1]   Complete coding sequence of hepatitis C virus genotype 6a [J].
Adams, NJ ;
Chamberlain, RW ;
Taylor, LA ;
Davidson, F ;
Lin, CK ;
Elliott, RM ;
Simmonds, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (02) :393-396
[2]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]  
BARTKE A, 1993, I C S S, V3, P67
[4]  
Barton DJ, 1996, METHOD ENZYMOL, V275, P35
[5]   CLONING AND CHARACTERIZATION OF A RNASE-L INHIBITOR - A NEW COMPONENT OF THE INTERFERON-REGULATED 2-5A PATHWAY [J].
BISBAL, C ;
MARTINAND, C ;
SILHOL, M ;
LEBLEU, B ;
SALEHZADA, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13308-13317
[6]  
Bisbal C, 2000, METH MOL B, V160, P183
[7]   Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication [J].
Blight, KJ ;
McKeating, JA ;
Rice, CM .
JOURNAL OF VIROLOGY, 2002, 76 (24) :13001-13014
[8]   Efficient initiation of HCV RNA replication in cell culture [J].
Blight, KJ ;
Kolykhalov, AA ;
Rice, CM .
SCIENCE, 2000, 290 (5498) :1972-1974
[9]   The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa [J].
Chamberlain, RW ;
Adams, NJ ;
Taylor, LA ;
Simmonds, P ;
Elliott, RM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (01) :44-49
[10]   Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East [J].
Chamberlain, RW ;
Adams, N ;
Saeed, AA ;
Simmonds, P ;
Elliott, RM .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1341-1347